SEC Form 4 · accession 0001140361-15-035079
Arbutus Biopharma Corp · ABUS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark J. Murray
Officer — President & CEO
Period of report
Sep 11, 2015
Accepted (ET)
Sep 15, 2015 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001447028
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Sep 11, 2015 | M | 219,428 | $0.4444 | A | 284,389 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $0.4444 | Sep 11, 2015 | M | 219,428 | D | Mar 30, 2008 | Sep 12, 2015 | Common shares | 219,428 | 0 | D |
Explanation of responses
- F1Expressed in Canadian dollars.